BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3377459)

  • 21. Pharmacokinetics of carumonam in patients with renal insufficiency.
    Horber F; Egger HJ; Weidekamm E; Dubach UC; Frey FJ; Probst PJ; Stoeckel K
    Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.
    Angehrn P
    Chemotherapy; 1985; 31(6):440-50. PubMed ID: 3935396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative non-blind trial of ceftriaxone and gentamicin in the treatment of complicated urinary tract infections.
    Lentini M; Castiello G; Scorza C; Calvosa F
    J Int Med Res; 1982; 10(3):166-78. PubMed ID: 6284564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens.
    Bérubé D; Vallée F; Panneton AC; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Mar; 32(3):354-7. PubMed ID: 3364953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of urinary tract infection with gentamicin once or three times daily.
    Chong CY; Tan AS; Ng W; Tan-Kendrick A; Balakrishnan A; Chao SM
    Acta Paediatr; 2003; 92(3):291-6. PubMed ID: 12725542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study of carumonam].
    Takebe K; Tamura T; Endo K; Irie T; Sekino K; Uehara O; Sagara M; Okamoto K
    Jpn J Antibiot; 1987 Nov; 40(11):1917-22. PubMed ID: 3444030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of gentamicin and netilmicin in the treatment of gram-negative infections.
    LeFrock JL; Carr BB; Blias F; Schell RF; Dematteo C; Tillotson JR
    Drug Intell Clin Pharm; 1985 Apr; 19(4):309-15. PubMed ID: 3891278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
    Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
    Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro antimicrobial activity of carumonam (Ro 17-2301) and its influence on the activity of other antibiotics.
    Hoepelman IM; Steyger G; Rozenberg-Arska M; Verhoef J
    Chemotherapy; 1987; 33(2):103-9. PubMed ID: 3568798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
    McNulty CA; Garden GM; Ashby J; Wise R
    Antimicrob Agents Chemother; 1985 Sep; 28(3):425-7. PubMed ID: 4073864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
    Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
    Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose daily gentamicin therapy in urinary tract infection.
    Labovitz E; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1974 Oct; 6(4):465-70. PubMed ID: 4157346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renoprotective role of nifedipine during gentamicin therapy: randomized controlled trial.
    Vlasic-Matas J; Rumboldt Z; Karelovic D
    Croat Med J; 2000 Dec; 41(4):417-22. PubMed ID: 11063766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics.
    Mosegaard A; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1975 Mar; 7(3):328-32. PubMed ID: 1137386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.
    Hohl P; von Graevenitz A; Zollinger-Iten J
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1593-4. PubMed ID: 3190188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with a single daily dose of gentamicin in urinary tract infection in relation to the site of infection.
    Prát V; Bohuslav V; Hatala M
    Infection; 1978; 6(1):29-31. PubMed ID: 344226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose gentamicin therapy of recurrent urinary tract infection in patients with normal urinary tracts.
    Khan AJ; Kumar K; Evans HE
    J Pediatr; 1987 Jan; 110(1):131-5. PubMed ID: 3794874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of carumonam.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1988; 14(10):665-7. PubMed ID: 3246211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.